top of page
About
Unephra enables at-home cardiovascular disease management by integrating personalized cardio-renal physiology into treatment. Our proprietary passive urine-monitoring technology turns every bathroom visit into real-time clinical insights shared between care teams and patients. This empowers healthcare providers to deliver proactive, tailored interventions that improve outcomes while reducing the cost of care.
Our Mission
Improving Quality of Care and Life Through Innovative Technology
Our Focus
At-Home Personalized Health Monitoring and Care for Heart Failure & Hypertensive Patients
Our Goal
Preventing Avoidable Hospitalizations while Reducing Patients Risk
Our Vision
A Future Where Personalized Health is More Accessible, Effortless and Effective
Our Values
Innovation, Quality, and Customer & User Centric Design
Proprietary Technology
Unephra sensing technology enables continuous monitoring of health and disease risks. It provides actionable insights for both care teams and patients based on personalized cardio-renal physiology and advanced urine analysis
Personalized Risk Assessment
Based on Cardio-Renal Physiological Model
Informed Data Processing
Advanced Machine Learning and Statistical Analysis
Smart Bio-Chemical Sensing
Adaptive Micro-Sensor Array for Urine Biomarker Measurement
Clients
Our Valued Customers and Partners
Permanente Medicine
Snyder Lab | Stanford
KeborMed
What Experts Say About Unephra
Team
The Driving Force Behind Empowering Personalized Health Through Innovation
CEO & Co-Founder
Farhad Taghibakhsh, PhD
Farhad is a seasoned professional in sensor and hardware design, with a focus on medical and biomedical applications. With extensive experience from his roles at Apple (Health), Intuitive Surgical, and Qualcomm, he holds a portfolio of innovative patents that reflect his expertise and forward-thinking approach.
Farhad holds a PhD degree in Electrical and Computer Engineering from the University of Waterloo and a post-doctorate training certificate from Stanford Medicine. He is committed to advancing personalized health monitoring and making meaningful contributions to healthcare technology.
Co-Founder & Medical Strategist
Pedram Fatehi, MD, MPH
Pedram is a Clinical Associate Professor of Medicine at Stanford University, triple board-certified in Internal Medicine, Nephrology, and in Critical Care Medicine. He is highly regarded for his expertise in evaluation and management of hypertension, shock, and kidney diseases. He actively contributes to the medical education of a wide range of trainees in clinical pathophysiology.
Dr. Fatehi received his Medical Doctorate degree from University of Texas; Master of Public Health from Yale University; Internal Medicine Residency and Nephrology Fellowship from Columbia University; and Critical Care Fellowship from UCSF, and he is committed to advancing patient care through innovation, education, and compassion.
Member of the Board & Advisor
Yasi Baiani
Yasi is the Founder & CEO of Raya Advisory and a LinkedIn Top Voice with 480K+ followers.
As an early Fitbit employee, she helped grow the company from 400 to 2,000+ employees and $745M to $2.2B in revenue. As Head of Product, Software Experiences, she led innovations like Sleep (the most-engaged Fitbit app feature) and Female Health (2.4M users in the first month).
At Cleo, she advanced from Strategy Consultant to SVP of Product & Marketing, launching Teens and Eldercare, unlocking a $270B+ market, and driving expansion among major clients like Salesforce and Uber.
She holds an MBA from Harvard Business School and a BS from UC Berkeley’s Haas School of Business.
bottom of page